BioStem Technologies, Inc.

NASDAQ:BSEM

Biotechnology

Healthcare
$3.07 -6.54%

-$0.21 today

Market cap
$52.14M
Beta
0.26
P/E (TTM)
-1.8
EPS (TTM)
-$1.63
52W Low $2.25High $8.40

Volume 0.09M

Average 0.07M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$9.94M

FY 2025 · Annual

-59.4% YoY

Investing Cash Flow

-$2.10M

FY 2025 · Annual

Financing Cash Flow

-$1.12M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(1.41M)(7.11M)(8.48M)31.88M(6.58M)
Depreciation & Amortization283.79K243.42K395.32K293.22K381.02K
Deferred Income Tax(689.36K)0003.99M
Stock-Based Compensation403.02K4.9M6.67M00
Change in Working Capital515.9K7.59K(3.54M)(12.01M)(3.98M)
Accounts Receivables(288.25K)262.93K(11.33M)(93.78M)4.43M
Inventory209.35K(135.18K)(263.45K)(1.17M)(1.05M)
Accounts Payables(19.49K)(77.14K)821.57K4.42M(1.5M)
Other Working Capital614.3K(43.03K)8.06M78.52M(5.86M)
Other Non-Cash Items788.99K322.58K1.46M4.31M16.12M
Operating Cash Flow(109.44K)(1.64M)(3.5M)24.48M9.94M
Capital Expenditures(42.85K)(469.48K)(105.33K)(426.57K)(3.35M)
Acquisitions (Net)35K0(105K)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities000(1.25M)1.25M
Investing Cash Flow(7.85K)(469.48K)(210.33K)(1.68M)(2.1M)
Debt Repayment232.42K547.71K797.06K(849.4K)(1.17M)
Common Stock Issued125K50K2.38M642.62K48.33K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(391.79K)0000
Financing Cash Flow357.42K597.71K3.18M(206.78K)(1.12M)
Effect of Forex Changes01.97M000
Net Change in Cash240.13K431.8K(532.73K)22.59M6.72M
Free Cash Flow(152.29K)(2.11M)(3.6M)24.05M6.59M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$6.6M
+ D&A$381.0K
+ Stock-Based Comp$0
+ Deferred Tax$4.0M
- Working Capital-$4.0M
+ Other Non-Cash$16.1M
= Operating Cash Flow$9.9M
- Capex-$3.4M
= Free Cash Flow$6.6M

Analysis

FY2025 free cash flow is $6.6M. FCF conversion is -100.1% of net income. Operating cash flow was $9.9M, with capex of -$3.4M. The largest bridge item is Other Non-Cash at $16.1M.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-1S-1 filingSep 18, 2026
8-KCurrent reportSep 18, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

Does BSEM generate free cash flow?

BioStem Technologies, Inc. (BSEM) generated $6.59M of free cash flow in fiscal 2025.

How much operating cash flow does BSEM produce?

Operating cash flow was $9.94M, before capital expenditures of $3.35M.